Visiongain publishes Biosensors Market Report 2020-2030

30 April 2020

Visiongain has launched a new pharma report Biosensors Market Report 2020-2030: Forecasts by Technology (Thermal, Electrochemical, Optical, Piezoelectric, Application (Medical (Cholesterol, Blood Gas Analyzer, Drug Discovery, Blood Glucose, Pregnancy Testing, Infectious Disease), Food Toxicity, Bioreactor, Agriculture, Environment, Others), End Use (Home Healthcare Diagnostics, PoC Testing, Food Industry, Research Laboratories, Security and Bio-defense), and Geography (North America, Latin America, Europe, Asia Pacific, MEA).

The global biosensors market is anticipated to grow at a lucrative CAGR of xyz% and anticipated to reach USD xyz billion by 2020. Visiongain anticipates that the global biosensors market will grow on account of the emergence of nanotechnology-based biosensors coupled with growing technological advancements in recent years.

To access the data contained in this document please email

Also, the global market for biosensors will see lucrative growth rates due to the growing applications of biosensors in the medical field. For example, wearable biosensors are of significant interest due to their ability to provide continuous, real-time physiological details by complex, non-invasive measurements of biochemical markers in biofluids such as blood, tears, saliva, and interstitial fluid. The latest innovations have centered on electrochemical and optical biosensors, along with improvements in the non-invasive detection of biomarkers, including metabolites, bacteria, and hormones.

The food producers across the globe are progressively demanding effective quality control methods to meet consumer & regulatory requirements to improve the feasibility of production, quality, automation, & cost and time reduction in production. In general, chemical and microbiological analyzes are performed periodically in the food and agricultural industries by trained operators, which are expensive and require extraction or sample pretreatment steps, thus increasing the analysis time. Biosensor technology can overcome all the inconveniences and offer affordable and fast quality control methods. Considering all these aspects biosensors are anticipated to play a vital role in industrial growth over the forecast period.

North America held the largest market share in the year 2019 owing to the growing prevalence of chronic diseases coupled with a growing preference for wearable biosensors. Also, the market will continue to be driven by the existence of the target population and increased R&D investment by important business organizations. Asia Pacific region is expected to experience the highest growth in terms of CAGR over the forecast period owing to the growing presence of target patient pool in markets such as India and China. Additionally, unmet needs of patients and untapped nations in this region have been attracting investments by global players and this is expected to boost the Biosensors Market growth over the forecast period.

Currently, key players are forming various strategies such as acquisitions, mergers, partnerships, collaborations, and launching new products to strengthen their position in the global biosensors market. Companies are also expanding their R&D, distribution, and management facilities to expand their business and to hold a competitive edge in the Biosensors Market.

The comprehensive market report features companies such as AZUR Environmental, Abbott Laboratories, Biosensor BV, Bayer AG, Cranfield Biotechnology Centre, DuPont Biosensor Materials, EG & IC Sensors Inc., Ercon, Inc., Innovative Biosensors Inc., Johnson & Johnson, LifeScan, Inc., Molecular Devices Corp., Pinnacle Technologies Inc., Sysmex Corporation, QTL Biosystems, Roche Diagnostics among other prominent players. Also the research study offers market estimation and forecast for the period ranging 2020-2030 for global markets such as North America, Latin America, Europe, Asia Pacific and MEA along with regional sub-markets as U.S., Canada, Brazil, Mexico, Germany, UK, France, Italy, Spain, Russia, India, Japan, China, Australia, ASEAN, GCC and South Africa.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to or call her on +44 (0) 20 7549 9987.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Biopharmaceuticals Contract Manufacturing Market Report 2022-2032

Ageing population will be more susceptible to such diseases and is one of the key factors driving the growth of the global biological drugs market. In most of the developed world, the share of elderly population is almost touching a quarter of the population.

26 January 2022


Visiongain Publishes Topical Drug Delivery Market Report 2022-2032

Some of the factors driving the market growth are the increasing prevalence of skin and eye diseases, high incidences of burn incidences and the growing prevalence of diabetes.

26 January 2022


Visiongain Publishes Decentralized Clinical Trials Market Report 2022-2032

The growing adoption advanced e-clinical solutions, rising focus on clinical research, increasing investment in R&D, and adoption of decentralized clinical trials by biopharmaceutical companies are some of the major factors that drive the growth of the global decentralized clinical trials market.

24 January 2022


Visiongain Publishes Nasal Drug Delivery Technology Market Report 2022-2032

The nasal drug delivery market will expand rapidly due to rising patient preference for nasal medication delivery due to ease of administration and efficacy, increased self-administration practises, and increased demand for home healthcare equipment.

18 January 2022